Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A robust deep learning model for the classification of dental implant brands.
Leblebicioglu Kurtulus I, Lubbad M, Yilmaz OMD, Kilic K, Karaboga D, Basturk A, Akay B, Nalbantoglu U, Yilmaz S, Ayata M, Pacal I. Leblebicioglu Kurtulus I, et al. Among authors: basturk a. J Stomatol Oral Maxillofac Surg. 2024 Sep;125(5S1):101818. doi: 10.1016/j.jormas.2024.101818. Epub 2024 Mar 8. J Stomatol Oral Maxillofac Surg. 2024. PMID: 38462066
A comprehensive review of deep learning in colon cancer.
Pacal I, Karaboga D, Basturk A, Akay B, Nalbantoglu U. Pacal I, et al. Among authors: basturk a. Comput Biol Med. 2020 Nov;126:104003. doi: 10.1016/j.compbiomed.2020.104003. Epub 2020 Sep 17. Comput Biol Med. 2020. PMID: 32987202 Review.
The role of ruxolitinib in the management of acute GVHD.
Namdaroglu S, Hidayet E, Aydin MS, Erkurt MA, Berber I, Cinar OE, Ozet G, Yilmaz S, Apaydin M, Dal MS, Korkmaz S, Basturk A, Ulaş T, Altuntas F. Namdaroglu S, et al. Among authors: basturk a. Transfus Apher Sci. 2024 Dec 16;64(1):104055. doi: 10.1016/j.transci.2024.104055. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39719750
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?
Ulas T, Namdaroglu S, Hindilerden IY, Erkurt MA, Erer K, Yigenoglu TN, Tiryaki TO, Hidayet E, Korkmaz S, Ulu BU, Yilmaz S, Kaya E, Pepeler MS, Basturk A, Dal MS, Altuntas F. Ulas T, et al. Among authors: basturk a. Transfus Apher Sci. 2024 Dec 17;64(1):104058. doi: 10.1016/j.transci.2024.104058. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39700842 Review.
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study.
Ozen A, Chongsrisawat V, Sefer AP, Kolukisa B, Jalbert JJ, Meagher KA, Brackin T, Feldman HB, Baris S, Karakoc-Aydiner E, Ergelen R, Fuss IJ, Moorman H, Suratannon N, Suphapeetiporn K, Perlee L, Harari OA, Yancopoulos GD, Lenardo MJ; Pozelimab CHAPLE Working Group. Ozen A, et al. Lancet. 2024 Feb 17;403(10427):645-656. doi: 10.1016/S0140-6736(23)02358-9. Epub 2024 Jan 23. Lancet. 2024. PMID: 38278170 Clinical Trial.
68 results